As molecule complexity rises, advanced cell line development platforms are giving biopharma companies new tools to overcome ...
For small startups and academic spinoffs bringing their first molecules to market, reaching the clinic represents a major milestone. Reducing the time to investigate a new drug (IND) filing can help ...
Boston, July 14, 2026 (GLOBE NEWSWIRE) -- Artificial intelligence is fundamentally reshaping pharmaceutical development, with AI-driven drug discovery attracting over $2 billion in recent investment ...
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results